Whether monitoring chronic illnesses or tracking fitness levels, consumers have become much more interested in capturing their own health data—and engaging more in their own wellness. This unprecedented collection of information can potentially provide clinicians with a more holistic view of patients’ lives outside the clinical setting.


Putting PGHD under the microscope

The U.S. Department of Health and Human Services - Office of the National Coordinator for Health Information Technology (ONC) is helping to explore the potential of PGHD. After identifying PGHD use as an important issue for advancing patient engagement, care delivery, and research, ONC initiated a series of activities to gain more information about its value and approaches to implementing it. Building on prior policy work, ONC began collaborating with Accenture Federal Services in 2015. The goal: to dig deep into what’s possible, what’s standing in the way, and options for overcoming those barriers.

Accenture conducted research and industry outreach to better understand how organizations are currently using PGHD, as well as the challenges impeding its successful utilization. The project team explored seven different policy topic areas relevant to PGHD, developed extensive environmental scans and literature reviews, met with more than 60 industry subject-matter experts, and coordinated two pilot demonstrations to test the findings in a real-world clinical setting. The research helped to identify best practices, gaps, and opportunities for progress in the capture, use, and sharing of PGHD.

Patient-generated healthcare white paper

The resulting white paper, Conceptualizing a Data Infrastructure for the Capture, Use, and Sharing of Patient-Generated Health Data in Care Delivery and Research through 2024, suggests actions that patients and caregivers, clinicians, researchers, policymakers, developers and standards bodies, and payers and employers can take to collaborate and advance the use of PGHD. Ultimately, it lays the groundwork for creating a well-defined yet flexible policy framework to help in unleashing PGHD’s potential for all healthcare stakeholders.

Recognizing the need for guidance and best practices for incorporating PGHD into care delivery and research, the team also created a Practical Guide that offers suggested practices and questions to consider when implementing PGHD capture and use.

What Accenture did

The team set out to understand the key barriers to greater use of PGHD. The white paper points to a number of challenges around the capture, use, and sharing of PGHD. Among them:

Patients may not understand the advantages of capturing and sharing their data with clinicians and researchers. Not all patients have access to technologies that capture, use and share PGHD. Patients may have varying levels of health and technology literacy. What’s more, their concerns about data privacy and security may prevent them from participating.

Healthcare systems, clinical practices, and research institutions may not have the technical infrastructure, functional workflows, workforce capacity, and training to support PGHD intake. They may be unsure how to generate actionable insights from the voluminous data. And, they may worry about how PGHD could add to their workloads and disrupt their workflows.

All healthcare stakeholders may face data- and device-related concerns. For example, consumers may abandon their devices, and researchers may be challenged to verify the accuracy and validity of PGHD from wellness devices. For clinicians, PGHD use may introduce new liability concerns. What if inaccurate PGHD is used in clinical decisions? What if a physician chooses not to review or act on PGHD received? Meanwhile, the devices introduce new security risks, and they produce data which need to be standardized against other formats before it can be helpful.

Enabling change

While the team focused on articulating the challenges, they also worked to devise potential solutions. To advance the use of PGHD, the white paper proposes a series of “enabling actions” for everyone in the healthcare ecosystem.

Value delivered

Piloting PGHD in real-world settings

An important goal of the project was to test the initial findings and recommendations in the real world for inclusion in the final white paper. Accenture engaged with two digital health technology organizations and their care delivery partners to see how the concepts would perform with actual clinicians and patients:

TapCloud and its partner, AMITA Health, worked together to collect PGHD across several medical areas—including orthopedic surgery, behavioral health, and bariatric surgery.

The pilot engaged patients in identifying and collecting their symptoms, pain ratings, activity levels, and self-assessments of how they felt compared to the previous day. TapCloud and AMITA Health then incorporated that data into a dashboard that clinical staff reviewed. The pilot demonstration showed how a single technology platform enables effective use of PGHD for a variety of medical conditions, clinical settings, clinician roles, and patient populations. Results included a readmission rate drop from a baseline of 5.1 percent to 2 percent for the Orthopedic surgery TapCloud platform users.

Validic and its partners conducted a pilot demonstration focused on diabetes care. The project addressed two core goals: to see how PGHD collected from a variety of glucometers could inform diabetes care and to assess the infrastructure and workflows needed to implement and scale these kinds of initiatives.

Historically, many diabetes patients have had to keep written logs of their at-home test results. It’s virtually impossible for a physician to review and glean meaningful insights from binders of paper-based data. In the pilot, patients using traditional glucometers were able to simply snap a smart-phone picture of their readings. The Validic technology converted that information into structured data that was then fed into existing workflows and systems. With convenient access to the data, clinicians were able to more readily spot trends and advise patients on ways to improve their levels. The pilot demonstration included ethnography to identity areas of improvement to further patient and provider engagement. Key learnings included the need to proactively engage and sustain patients in ways that could be scalable and sustainable by the healthcare provider.

Studying policy areas

At the heart of the project is the team’s examination of seven PGHD policy topic areas:

  1. Patient Recruitment for Research Studies and Trials: how PGHD can be used to identify patients for research studies and trials and to connect patients directly with researchers.
  2. Collection and Validation of Data and Tools: exploring existing and emerging tools for capturing PGHD, as well as the types of PGHD that clinicians and researchers collect and how they validate the data and tools.
  3. Data Donation: studying patient expectations for sharing data with clinicians and researchers, including existing and emerging methods for “donating” data for research.
  4. Ability to Combine PGHD with Medical Record Data in Multiple Ways: examining opportunities to combine PGHD with clinical data for analysis and patient care, including methods for combining data from multiple sources and standards and technology needed to support this practice.
  5. Data Interoperability: researching benefits of and barriers to increased interoperability between the health IT system and devices used to capture PGHD.
  6. Big Data Analysis: assessing the technical and cultural challenges to using PGHD in big data analysis, including patient concerns about data privacy, storing and transmitting potentially large volumes of data, and providing clinically useful presentations of PGHD.
  7. Regulatory Overview: discussing the current federal statutory and regulatory paradigms relevant to PGHD, including the tools and technologies used to capture PGHD.

PGHD adoption

2012-2015: Exploration & investment

  • Explosion in the popularity of consumer health devices
  • Government exploration of PGHD opportunities
  • Patients collect PGHD, but don’t share it.

2016-2017: Early adoption

  • Organizations see the value of PGHD and begin exploring the use for chronic diseases
  • Precision medicine and telehealth increase the focus of PGHD

2018-2024: Growth

  • More patients willing to share PGHD
  • Interoperability supports capture, use & sharing of PGHD
  • Clinicians store PGHD with few liability concerns

2024: Maturity

  • PGHD seamlessly flows to clinicians
  • Patient + providers are collaborative
  • Patients are engaged & monitor their health

View All
Accenture’s work with ONC affirmed the potential value of PGHD in care delivery and health research. It provides flexible and actionable recommendations for how healthcare stakeholders can collaborate to realize that value together.

Meet our lead

Subscription Center
Stay in the know with our newsletters Stay in the know with our newsletters